CO2 as a raw material becomes a "game changer" for the industry
CO2 emissions equivalent to what 2,200 cars produce in a year can be turned into new products using biotechnology. In the EU project PyroCO2, the greenhouse gas CO2 will become a profitable business, at the same time the project will contribute to zero emissions and a sustainable economy.
SINTEF researcher appointed as a fellow at AIMBE
Ruth Schmid is one of the leading researchers in nanomedicine in Europe and the list of international top positions in chemistry and nanomedicine has grown throughout her career. Now, she has been appointed another prestigious role: Fellow at The American Institute of Medical and Biological Engineering (AIMBE).
Bacteria-based concrete offers climate benefits
Ten cubic kilometres of concrete, equivalent to the volume of Mount Everest, are used in construction projects every year, resulting in huge volumes of emissions. But a new eco-friendly cement may help to reduce our global climate footprint.
How safe are the new Covid vaccines?
The new vaccines designed to combat the Covid-19 virus have been developed in record time, causing some people to be sceptical of taking them. Should we be worried about side effects? Norwegian SciTech News has been talking to two research scientists about this issue.
Getting the body to make its own cancer drugs
Imagine that we could instruct our bodies to make the drugs they need themselves. The gene technology that makes this possible is called mRNA therapy, which may become a major tool in the treatment of multiple diseases. Norwegian researchers are currently helping to develop a drug of this kind to treat the most aggressive form of breast cancer.
EU-OPENSCREEN ERIC: EU initiative supports research on future medical chemistry
Use EU-OPENSCREEN ERIC’s newly funded EU-OPENSCREEN-DRIVE project to advance your research now.
Experiments show that an “unknown” enzyme fights inflammation
An enzyme that normally repairs damaged DNA may be the key to a new treatment for inflammatory diseases.
Hoping to treat osteoarthritis using artificial cartilage tissue
A Norwegian-Swiss research team has succeeded in growing cartilage tissue cells using algae. Moreover, the new cells can reduce joint inflammation. This news gives hope for people suffering from arthrosis, also known as osteoarthritis.
New allergy test promises safer antibiotic use
Allergies to antibiotics are the commonest form of medication allergies and, in the worst cases, can result in anaphylaxis and death. SINTEF is participating in the development of a new allergy test that will make it easier to provide patients with safe and correct treatments.